Noveris Health Sciences is trading 15.62% up at CA$0.18, with no new August 24, 2026 company announcement or reliable report clearly explaining the move.
- The latest identified disclosure was an August 20, 2026 proposal for up to CA$500,000 of convertible debentures, expected to close August 28.
- Available coverage does not directly link the proposal to the August 24 gain.
- Recent volatility suggests flow-driven trading; no volume data was provided.